BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CML. (Q35849671)
Jump to navigation
Jump to search
scientific article published on 7 February 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CML. |
scientific article published on 7 February 2006 |
Statements
1 reference
BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CML. (English)
1 reference
Zac Love
1 reference
Ashlie A Tronnes
1 reference
Rui Yang
1 reference
Thuan Tran
1 reference
Solange Mongoue-Tchokote
1 reference
Motomi Mori
1 reference
Michael J Mauro
1 reference
Michael W Deininger
1 reference
1 reference
1 reference
Identifiers
1 reference